Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher Disease

Gaucher disease (GD) is caused by mutations in the <i>GBA</i> gene, leading to deficient activity of the lysosomal enzyme glucocerebrosidase. Among all the symptoms across various organ systems, bone disease is a major concern as it causes high morbidity and reduces quality of life. Enzyme replaceme...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Renuka P. Limgala, Ozlem Goker-Alpan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2020-03-01
coleção:	Biomolecules
Assuntos:	Gaucher disease bone involvement enzyme replacement therapy substrate reduction therapy Osteoimmunology RANK/RANKL
Acesso em linha:	https://www.mdpi.com/2218-273X/10/4/526
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!